Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06005038 · ClinicalTrials.gov registry record · Phase 1

CogT pSOPT Intervention Study

A Phase 1 study of Mild Cognitive Impairment and Subjective Cognitive Impairment, sponsored by Stanford University.

Recruiting
Registry status
Phase 1
Development phase
50
Enrollment target
1
Study location

NCT06005038 is a Phase 1 study of Mild Cognitive Impairment and Subjective Cognitive Impairment that is actively recruiting participants, run by Stanford University. The registered enrollment target is 50 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06005038, a Phase 1 study of Mild Cognitive Impairment and Subjective Cognitive Impairment, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
Phase 1
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

(JUSTIFICATION: This is the R33 stage of an NIH funded R21/R33 study. R21 stage (IRB-61727) was focused on intervention development; R33 stage will focus on pilot testing the effect of the intervention. The R21 phase was not considered a NIH defined clinical trial; R33 will be considered a NIH defined clinical trial) The purpose is to develop and test the effect of a "personalized" computer-based cognitive training program. The personalized program tailors the difficulty of the training tasks using a participant's biofeedback (i.e., heart rate) and cognitive performance. Such a personalization will ensure that the participant can perform at his/her ideal training capacity. Participants will be randomized into one of 2 groups and each group will play a different version of computerized training game and have ECG collected to allow subject blinding.

Conditions Studied

Mild Cognitive Impairment Subjective Cognitive Impairment

Interventions

  • BEHAVIORAL pSOPT
  • BEHAVIORAL MLA

Study Locations (1)

California

  • CogT Lab, Stanford University - Palo Alto

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-01-12
Est. Completion 2026-12-31
Phase Phase 1

Sponsor

Stanford University

1,744 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06005038

The ClinicalTrials.gov registry entry for NCT06005038 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (96% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which pSOPT is the first listed.

NCT06005038 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06005038 about?

NCT06005038 is a clinical study titled "CogT pSOPT Intervention Study". (JUSTIFICATION: This is the R33 stage of an NIH funded R21/R33 study. R21 stage (IRB-61727) was focused on intervention development; R33 stage will focus on pilot testing the effect of the intervention. The R21 phase was not considered a NIH defined clinical trial; R33 will be considered a NIH defin...

What is the current status of trial NCT06005038?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2024-01-12. Estimated completion is 2026-12-31.

What conditions does trial NCT06005038 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Subjective Cognitive Impairment.

What interventions are being tested in trial NCT06005038?

The interventions under investigation include: pSOPT (BEHAVIORAL), MLA (BEHAVIORAL).

Who is sponsoring clinical trial NCT06005038?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06005038 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Mild Cognitive Impairment

All registered trials for this condition

Subjective Cognitive Impairment

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.